Cargando…

Allergen Immunotherapy Reverses Immune Response to SARS-CoV-2 Vaccine in Patients with Allergic Rhinitis: A Prospective Observational Trial

Detalles Bibliográficos
Autores principales: Yao, Yin, Huang, Ao, Deng, Yi-Ke, Liu, Yan, Zhu, Hong-Yu, Wang, Nan, Wang, Zhe-Zheng, Zhu, Rong-Fei, Yu, Di, Liu, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799121/
https://www.ncbi.nlm.nih.gov/pubmed/35649178
http://dx.doi.org/10.1164/rccm.202203-0608LE
_version_ 1784861048935809024
author Yao, Yin
Huang, Ao
Deng, Yi-Ke
Liu, Yan
Zhu, Hong-Yu
Wang, Nan
Wang, Zhe-Zheng
Zhu, Rong-Fei
Yu, Di
Liu, Zheng
author_facet Yao, Yin
Huang, Ao
Deng, Yi-Ke
Liu, Yan
Zhu, Hong-Yu
Wang, Nan
Wang, Zhe-Zheng
Zhu, Rong-Fei
Yu, Di
Liu, Zheng
author_sort Yao, Yin
collection PubMed
description
format Online
Article
Text
id pubmed-9799121
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Thoracic Society
record_format MEDLINE/PubMed
spelling pubmed-97991212022-12-30 Allergen Immunotherapy Reverses Immune Response to SARS-CoV-2 Vaccine in Patients with Allergic Rhinitis: A Prospective Observational Trial Yao, Yin Huang, Ao Deng, Yi-Ke Liu, Yan Zhu, Hong-Yu Wang, Nan Wang, Zhe-Zheng Zhu, Rong-Fei Yu, Di Liu, Zheng Am J Respir Crit Care Med Correspondence American Thoracic Society 2022-06-01 /pmc/articles/PMC9799121/ /pubmed/35649178 http://dx.doi.org/10.1164/rccm.202203-0608LE Text en Copyright © 2022 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . For commercial usage and reprints, please e-mail contact Diane Gern (dgern@thoracic.org).
spellingShingle Correspondence
Yao, Yin
Huang, Ao
Deng, Yi-Ke
Liu, Yan
Zhu, Hong-Yu
Wang, Nan
Wang, Zhe-Zheng
Zhu, Rong-Fei
Yu, Di
Liu, Zheng
Allergen Immunotherapy Reverses Immune Response to SARS-CoV-2 Vaccine in Patients with Allergic Rhinitis: A Prospective Observational Trial
title Allergen Immunotherapy Reverses Immune Response to SARS-CoV-2 Vaccine in Patients with Allergic Rhinitis: A Prospective Observational Trial
title_full Allergen Immunotherapy Reverses Immune Response to SARS-CoV-2 Vaccine in Patients with Allergic Rhinitis: A Prospective Observational Trial
title_fullStr Allergen Immunotherapy Reverses Immune Response to SARS-CoV-2 Vaccine in Patients with Allergic Rhinitis: A Prospective Observational Trial
title_full_unstemmed Allergen Immunotherapy Reverses Immune Response to SARS-CoV-2 Vaccine in Patients with Allergic Rhinitis: A Prospective Observational Trial
title_short Allergen Immunotherapy Reverses Immune Response to SARS-CoV-2 Vaccine in Patients with Allergic Rhinitis: A Prospective Observational Trial
title_sort allergen immunotherapy reverses immune response to sars-cov-2 vaccine in patients with allergic rhinitis: a prospective observational trial
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799121/
https://www.ncbi.nlm.nih.gov/pubmed/35649178
http://dx.doi.org/10.1164/rccm.202203-0608LE
work_keys_str_mv AT yaoyin allergenimmunotherapyreversesimmuneresponsetosarscov2vaccineinpatientswithallergicrhinitisaprospectiveobservationaltrial
AT huangao allergenimmunotherapyreversesimmuneresponsetosarscov2vaccineinpatientswithallergicrhinitisaprospectiveobservationaltrial
AT dengyike allergenimmunotherapyreversesimmuneresponsetosarscov2vaccineinpatientswithallergicrhinitisaprospectiveobservationaltrial
AT liuyan allergenimmunotherapyreversesimmuneresponsetosarscov2vaccineinpatientswithallergicrhinitisaprospectiveobservationaltrial
AT zhuhongyu allergenimmunotherapyreversesimmuneresponsetosarscov2vaccineinpatientswithallergicrhinitisaprospectiveobservationaltrial
AT wangnan allergenimmunotherapyreversesimmuneresponsetosarscov2vaccineinpatientswithallergicrhinitisaprospectiveobservationaltrial
AT wangzhezheng allergenimmunotherapyreversesimmuneresponsetosarscov2vaccineinpatientswithallergicrhinitisaprospectiveobservationaltrial
AT zhurongfei allergenimmunotherapyreversesimmuneresponsetosarscov2vaccineinpatientswithallergicrhinitisaprospectiveobservationaltrial
AT yudi allergenimmunotherapyreversesimmuneresponsetosarscov2vaccineinpatientswithallergicrhinitisaprospectiveobservationaltrial
AT liuzheng allergenimmunotherapyreversesimmuneresponsetosarscov2vaccineinpatientswithallergicrhinitisaprospectiveobservationaltrial